Proteinuria Evaluation and Management

Introduction to Proteinuria

A urine protein concentration of 30mg/dl or a protein-to-creatinine ratio of approximately 300mg/g indicates significant proteinuria that requires medical evaluation and intervention, suggesting kidney damage that could progress to chronic kidney disease if left untreated 1, 2

Repeat testing with a first morning urine sample for protein-to-creatinine ratio should be performed to confirm proteinuria, and if the initial test was dipstick, confirmation with quantitative measurement is necessary 1, 2

Measure serum creatinine and estimate GFR to assess kidney function, and check for other markers of kidney damage (hematuria, casts) and screen for conditions associated with proteinuria, such as diabetes mellitus and hypertension 1

In pregnant patients, proteinuria of 30mg/dl requires immediate evaluation for preeclampsia 3
The Kidney International guidelines recommend against using the term "microalbuminuria" and recommend titrating ACE inhibitors/ARBs to maximum tolerated dose, with a permissible increase in serum creatinine of up to 30% 1

The Kidney Disease Improving Global Outcomes (KDIGO) guidelines categorize albuminuria as follows:
Category Albuminuria Level
A1 (Normal to mildly increased) <30 mg/g (<3 mg/mmol)
A2 (Moderately increased) 30-299 mg/g (3-29 mg/mmol)
A3 (Severely increased) ≥300 mg/g (≥30 mg/mmol)
4
A urine albumin:creatinine ratio (UACR) of ≥300 mg/g indicates severely increased albuminuria (macroalbuminuria), representing significant kidney damage and requiring immediate medical intervention 4
Normal protein-to-creatinine ratio is <30 mg/g creatinine (or <0.3 mg/mg), according to the American Heart Association and the American Diabetes Association 5, 3

First-line therapy for patients with proteinuria should include an ACE inhibitor or ARB, titrated to maximum tolerated dose, with regular monitoring of serum creatinine and potassium, as recommended by the American College of Cardiology, Kidney International, and American Diabetes Association 6, 7, 8, 9
Target blood pressure should be ≤125/75 mmHg for patients with severe proteinuria (>1 g/day) and <130/80 mmHg for patients with albuminuria, as recommended by the American College of Cardiology, American Heart Association, and American Diabetes Association 6, 10, 8
For persistent proteinuria ≥1 g/day despite 3-6 months of optimized supportive care, consider a 6-month course of corticosteroids, as recommended by the American College of Cardiology and other guideline societies 6
Add potassium-wasting diuretics if needed to control edema and manage hyperkalemia, with caution to avoid increasing vasopressin levels, as reported by the Nature Reviews Nephrology 7, 11
Restrict dietary sodium to <2.0 g/day (<90 mmol/day) and consider protein restriction (target 50% reduction in protein intake) to help manage proteinuria, as recommended by the American Heart Association and other guideline societies 7

Regular exercise, smoking cessation, and moderate alcohol consumption are recommended to help manage proteinuria and reduce the risk of complications, as recommended by the American College of Cardiology and other guideline societies 7, 12
Normalize weight if overweight, as part of a comprehensive approach to managing proteinuria, and consider a low-salt, moderate-potassium diet, weight loss, and regular physical activity 7, 13

Monitor serum creatinine, potassium, and albumin regularly to assess treatment response and adjust therapy as needed, with a target of achieving at least 30% reduction in proteinuria, and an ideal goal of <1 g/day 6
Check urine protein-to-creatinine ratio every 4-6 weeks to assess treatment response, and adjust therapy as needed, and monitor UACR every 3-6 months to assess disease progression and treatment response 6, 14
Treatment goal is to achieve at least a 30% reduction in UACR with treatment, with an ideal target of achieving UACR <30 mg/g, as recommended by the Kidney Disease Improving Global Outcomes (KDIGO) guidelines 4

Prompt referral to a nephrologist is indicated, especially if eGFR <30 mL/min/1.73 m², or for rapidly declining kidney function or uncertainty about etiology, as recommended by the Kidney International guideline society and American Journal of Kidney Diseases 14, 7, 15
Consider referral when proteinuria >3.5 g/day (nephrotic range), rapidly declining kidney function, eGFR <30 mL/min/1.73 m², or active urinary sediment 7, 15
Monitor for complications of massive proteinuria, including hypoalbuminemia, edema, hyperlipidemia, and hypercoagulable state, and consider statin therapy or thromboprophylaxis as needed, particularly in membranous nephropathy, as reported by the American Journal of Kidney Diseases 7, 16